Marlboro-based Cytyc Corp. has announced that its cash per share offer for Vision Systems Limited will remain open for acceptance by Vision Systems shareholders until November 17.
Cytyc has made an unconditional $3.25 cash per share offer to acquire Vision Systems, an Australian company specializing in automated instruments and reagents for biopsy-based detection of cancer and infectious diseases in pathology laboratories. The offer was made on October 2.
The offer will remain open unless withdrawn or extended further in accordance with the Australian Corporations Act. Vision Systems shareholders accepting the unconditional offer will receive cash for their securities within five days of accepting Cytyc’s offer.
